Navigation Links
Genomics of Cardiovascular Disease: Current Clinical Applications
Date:6/5/2008

KEYNOTE SPEAKER - Kari Stefansson, MD, DR. MED, CEO DeCODE Genetics

WASHINGTON, June 5 /PRNewswire-USNewswire/ -- The following media advisory was issued today by The Cheney Cardiovascular Institute:

Date: Thursday, June 12, 2008

Location: The George Washington University Hospital Auditorium

900 23rd Street, NW

Time: Noon - 2:50pm

Noon - 1:00pm Presentation by Dr. Kari Stefansson

Dr. Stefansson is CEO and co-founder of deCODE genetics and a former professor of neurology, neuropathology, and neuroscience at Harvard University.

The deCODE group has identified unique genomic markers for atherosclerosis, atrial fibrillation, and type II diabetes mellitus. As one of the world's leading experts on genomics, Dr. Stefansson will discuss the current clinical applications of cardiovascular personalized medicine. Key to understanding the potential of genomics, Dr. Stefansson will define single nucleotide polymorphisms (SNPs) and their role in genetic diseases. His talk will highlight the breakthroughs in cardiovascular genomics for both clinical cardiologists as well as researchers.

1:15 - 2:50pm Luncheon panel discussion -

Moderated by Timothy McCaffrey, PhD

Stephen B. Liggett, MD

Professor of Medicine and Physiology

Director, Cardiopulmonary Genomics

University of Maryland School of Medicine

Timothy McCaffrey, PhD

Professor of Biochemistry and Director, McCormick Genomics Center, The George Washington University School of Medicine

Gualberto Ruano, MD, PhD

President and CEO, Genomas, Inc.

The Richard B. and Lynne V. Cheney Cardiovascular Institute at The George Washington University was established in 2006 by a generous charitable contribution from Vice President Richard Cheney and his wife Lynne.

The mission of The Richard B. and Lynne V. Cheney Cardiovascular Institute is to promote clinical research, education, patient care and community service with the goal of accelerating the pace of scientific discovery, reducing mortality and improving the quality of life of Americans with cardiovascular disease. To achieve these goals, the Institute seeks to provide an interdisciplinary structure to integrate basic and clinical investigators, clinicians, medical educators, health policy experts and community leaders. For more information, please visit http://www.cheneycardioinstitute.com.


'/>"/>
SOURCE The Cheney Cardiovascular Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Navigenics Proposes Standards for Personal Genomics Services, Coupled With Prospective Outcomes Studies, to Safeguard Consumers
2. Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACCs 57th Annual Scientific Session
3. AutoGenomics Receives FDA Clearance for its INFINITI(TM) Warfarin Assay
4. NIH announces new initiative in epigenomics
5. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
6. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
7. NeoGenomics Announces Results for the 3rd Quarter 2007
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
11. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: